Clinical efficacy and safety outcomes of bempedoic acid for LDL-C lowering therapy in patients at high cardiovascular risk: a systematic review and meta-analysis

OBJECTIVES: Bempedoic acid (BA) is a novel oral low-density lipoprotein cholesterol lowering drug. This systematic review and meta-analysis aims to assess efficacy and safety for clinical outcomes in high cardiovascular (CV) risk patients. DATA SOURCES: MEDLINE, Cochrane Central Register of Controll...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yingfeng, Parco, Claudio, Karathanos, Athanasios, Krieger, Torben, Schulze, Volker, Chernyak, Nadja, Icks, Andrea, Kelm, Malte, Brockmeyer, Maximilian, Wolff, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883220/
https://www.ncbi.nlm.nih.gov/pubmed/35210334
http://dx.doi.org/10.1136/bmjopen-2021-048893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883220/
https://www.ncbi.nlm.nih.gov/pubmed/35210334
http://dx.doi.org/10.1136/bmjopen-2021-048893

Ejemplares similares